Evidence map›Paper›PMID 25253729›Full record

ArticleBiology of reproduction2014

Progesterone receptor membrane component-1 (PGRMC1) and PGRMC-2 interact to suppress entry into the cell cycle in spontaneously immortalized rat granulosa cells.

John J Peluso, Daniel Griffin, Xiufang Liu, Meghan Horne

Open access · bronzeAbstract read
In one paragraph

Article in Biology of reproduction, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. PGRMC1: An enigmatic heme-binding protein.Pharmacology & therapeutics · 2023
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

John J PelusoDepartment of Cell Biology, University of Connecticut Health Center, Farmington, Connecticut Department of Obstetrics and Gynecology, University of Connecticut Health Center, Farmington, Connecticut peluso@nso2.uchc.edu.
Daniel GriffinDepartment of Obstetrics and Gynecology, University of Connecticut Health Center, Farmington, Connecticut.
Xiufang LiuDepartment of Cell Biology, University of Connecticut Health Center, Farmington, Connecticut.
Meghan HorneDepartment of Cell Biology, University of Connecticut Health Center, Farmington, Connecticut.
UConn Health · US

Funding

PAIRBP & PGRMC1 act as a membrane receptor complex to mediate P4's ovarian actionR01HD052740 · NICHD · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI PELUSO, JOHN J · 2007 to 2011
$1.7M
NICHD NIH HHS R01 HD 052740NICHD NIH HHS R01 HD052740
6 · The paper itself

Abstract

Progesterone receptor membrane component 1 (PGRMC1) and PGRMC2 are expressed in rat granulosa cells and spontaneously immortalized granulosa cells (SIGCs) but their biological roles are not well defined. The present studies demonstrate that depleting either Pgrmc1 or Pgrmc2 in SIGCs increases entry into the cell cycle but does not increase cell proliferation. Rather, PGRMC1 and/or PGRMC2-deplete cells accumulate in metaphase and undergo apoptosis. Because both PGRMC1 and PGRMC2 localize to the mitotic spindle, their absence likely accounts for cells arresting in metaphase. Moreover, pull-down assays, colocalization studies and in situ proximity ligation assays (PLA) indicate that PGRMC1 binds PGRMC2. Disrupting the PGRMC1:PGRMC2 complex through the use of siRNA or the cytoplasmic delivery of a PGRMC2 antibody increases entry into the cell cycle. Conversely, overexpressing either PGRMC1-GFP or GFP-PGRMC2 fusion protein inhibits entry into the cell cycle. Subsequent studies reveal that depleting PGRMC1 and/or PGRMC2 reduces the percentage of cells in G0 and increases the percentage of cells in G1. These observations indicate that in addition to their role at metaphase, PGRMC1 and PGRMC2 are involved in regulating entry into the G1 stage of the cell cycle. Interestingly, both PGRMC1 and PGRMC2 bind GTPase-activating protein-binding protein 2 (G3BP2) as demonstrated by pull-down assays, colocalization assays, and PLAs. G3bp2 siRNA treatment also promotes entry into the G1 stage. This implies that dynamic changes in the interaction among PGRMC1, PGRMC2, and G3BP2 play an important protein regulating the rate at which SIGCs enter into the cell cycle.

Indexed as

Cell CycleAnimalsCell Line, TransformedCell ProliferationDown-RegulationFemaleG1 PhaseGranulosa CellsMembrane ProteinsMitosisProtein BindingRatsReceptors, ProgesteroneRNA, Small InterferingMembrane ProteinsPgrmc1 protein, ratPgrmc2 protein, ratReceptors, ProgesteroneRNA, Small Interferingapoptosisgranulosa cellsmitosisPGRMC1PGRMC2

Identifiers

PMID25253729
PMCPMC4434922
OpenAlexW2102704807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.